Teva’s criminal drug price-fixing deal with US DOJ leads to civil violations
Teva Pharmaceuticals’ admissions in a deferred prosecution agreement with the US Department of Justice’s criminal antitrust enforcers render the company liable for separate civil antitrust violations alleged by Humana, a Pennsylvania...To view the full article, register now.
Already a subscriber? Click here to view full article